Trial NCT00473824

View at ClinicalTrials.gov 
Org. Study IDs: Nabi-3104

Last trial update was posted on 2021-07-30

MeSH Interventions

Antibodies Immunoglobulins Immunoglobulins, Intravenous Rho(D) Immune Globulin gamma-Globulins

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C

Other Conditions

Evidence of Liver Transplantation Sequelae of Viral Hepatitis Transplantation Infection

Stopping Reasons

New sponsor's decision to pursue a redesigned clinical study

Limitations And Caveats

Early termination by sponsor due to data from the initial 7 patients of 36 planned for this study. Therefore, statistical analysis was not performed and no conclusion were reached regarding efficacy or drug safety.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID